← Back to signals
NBIX
STRONG BUYNeurocrine Biosciences Inc.
Health Care
0.23
PEGY ratio
Rank #64
Why This Matters
This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 101.6% annually over 5 years.
NBIX is trading at 23.0x earnings against 101.6% growth (no dividend), giving a PEGY of 0.23. The math suggests the stock is significantly undervalued relative to its growth and income profile.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
Scan date: 2026-05-08
Valuation
23.0x
P/E Ratio
Growth
101.6%
5yr EPS
Income
0.0%
Div Yield
PEGY Components
PEGY Score0.23
Denominator101.6%
EPS (TTM)$6.51
Market Data
Price$149.59
ExchangeNASDAQ
S&P 500
What Changed
PEGY Score
0.15→0.23(+0.07)
Rank
#28→#64(36 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only